{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"vip-benzo-withdrawal","title":"VIP for Benzodiazepine Withdrawal: Evidence Review","body":"## What's breaking down if you have Benzodiazepine withdrawal\n\nBenzodiazepine withdrawal involves GABA receptor changes after prolonged use. The brain adapts to the drug's enhancement of GABA activity. When the drug is reduced or stopped, this adaptation can lead to rebound excitability.\n\nCommon layers include autonomic nervous system shifts (such as heart rate and blood pressure changes), possible immune signaling adjustments, and disrupted sleep or mood regulation. These elements can persist because repair pathways for receptor sensitivity and neural balance take time to restore.\n\nNo direct condition profile matched the slug, so layers are inferred from typical withdrawal descriptions: GABAergic suppression does not rebuild neurochemistry.\n\n## Why VIP might help you\n\n1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP is studied in contexts of autonomic regulation and immune modulation. If autonomic instability contributes to symptoms during withdrawal, pathways involving VIP could relate to restoring balance rather than ongoing suppression.\n\n## Why Benzodiazepines matters for you\n\n**Drug:** Benzodiazepines\n\n**What it does:** GABAergic suppression; does not rebuild neurochemistry.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce acute symptoms but trades off against repair by not addressing underlying receptor or autonomic changes. Long-term use may prolong the need for external support instead of natural restoration.\n\n## How these fit together\n\nSingle-compound focus — VIP targets the immune / autonomic layer. Benzodiazepines act through suppression. The combination does not create synergy for repair; one addresses symptoms while the other is explored for potential tissue-level support.\n\n## What the evidence actually shows\n\nNo human trials link VIP directly to benzodiazepine withdrawal (mechanistic tier). No rat studies address this combination (preclinical tier absent). General VIP research exists on autonomic and immune functions but does not extend to withdrawal models.\n\n## What scientists say\n\nVIP research focuses on vasodilation, gut motility, and immune modulation in other contexts. No published statements connect it specifically to benzo withdrawal repair pathways.\n\n## What people say on Reddit\n\nDiscussions on peptides for benzo withdrawal mention other compounds but contain no references to VIP (anecdotal tier, no relevant posts).\n\n## What people say on X\n\nNo posts discuss VIP in relation to benzodiazepine withdrawal (anecdotal tier, zero relevant results).\n\n## What we do not know\n\nDirect effects of VIP on GABA receptor recovery, autonomic symptoms in withdrawal, or long-term outcomes remain unknown. Human data is absent.\n\n## Safety and limits\n\nVIP has been studied in limited clinical settings for other conditions. No safety data exists for this use case. All claims here are graded by available evidence tiers with no human data supporting the specific application.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/vip-benzo-withdrawal/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Benzodiazepine withdrawal involves GABA receptor downregulation and autonomic shifts.","section":"What's breaking down if you have Benzodiazepine withdrawal","tier":"mechanistic","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Establishes baseline layers for the condition.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human trials or animal studies link VIP to benzodiazepine withdrawal.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights absence of direct evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Benzodiazepines provide GABAergic suppression without rebuilding neurochemistry.","section":"Why Benzodiazepines matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames suppression vs repair distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP is associated with autonomic and immune modulation in general studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s0"],"source_status":"sourced","why_material":"Provides basis for layer targeting discussion.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/7439634/","title":"Neural release of vasoactive intestinal peptide from the gut","quote":"The release of vasoactive intestinal peptide (VIP) from the canine gut and its possible neural origin were studied...","summary":"Early study on VIP release from gut with neural implications.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:36:44.808Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"8ef8841367ee6b107b87d9045d1eb756ddf7ff2cf20f6d2cca7be0d119e684a2"},{"id":"s2","type":"medical","url":"https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+programs+and+practice+guidelines/substance+misuse+and+dependence/substance+withdrawal+management/benzodiazepine+withdrawal+management","title":"Benzodiazepine withdrawal management","quote":"Withdrawal is unlikely if the patient's use is intermittent only...","summary":"Clinical guidance on benzo withdrawal symptoms and management.","claim_ids":["c1","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:36:44.808Z","link_status":"ok","quote_status":"unverified","prev":"8ef8841367ee6b107b87d9045d1eb756ddf7ff2cf20f6d2cca7be0d119e684a2","hash":"2df62194ee7d04175f224f6d4d94401b3c5c9b944c2f20105e9c9b8fbceda498"},{"id":"s3","type":"other","url":"https://www.benzoinfo.com/bws/","title":"Benzodiazepine Withdrawal Syndrome (BWS)","quote":"People taking benzodiazepines regularly long term... may have symptoms of withdrawal...","summary":"Overview of benzo withdrawal syndrome.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:36:44.808Z","link_status":"ok","quote_status":"unverified","prev":"2df62194ee7d04175f224f6d4d94401b3c5c9b944c2f20105e9c9b8fbceda498","hash":"4127573958086c85ca4a21dce5d4030131e910a0e7f8e1a6f37160a9e0a25da9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:36:58.639Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"VIP for Benzodiazepine Withdrawal: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Benzodiazepine withdrawal\n\nBenzodiazepine withdrawal involves GABA receptor changes after prolonged use. The brain adapts to the drug's enhancement of GABA activity. When the drug is reduced or stopped, this adaptation can lead to rebound excitability.\n\nCommon layers include autonomic nervous system shifts (such as heart rate and blood pressure changes), possible immune signaling adjustments, and disrupted sleep or mood regulation. These elements can persist because repair pathways for receptor sensitivity and neural balance take time to restore.\n\nNo direct condition profile matched the slug, so layers are inferred from typical withdrawal descriptions: GABAergic suppression does not rebuild neurochemistry.\n\n## Why VIP might help you\n\n1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP is studied in contexts of autonomic regulation and immune modulation. If autonomic instability contributes to symptoms during withdrawal, pathways involving VIP could relate to restoring balance rather than ongoing suppression.\n\n## Why Benzodiazepines matters for you\n\n**Drug:** Benzodiazepines\n\n**What it does:** GABAergic suppression; does not rebuild neurochemistry.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce acute symptoms but trades off against repair by not addressing underlying receptor or autonomic changes. Long-term use may prolong the need for external support instead of natural restoration.\n\n## How these fit together\n\nSingle-compound focus — VIP targets the immune / autonomic layer. Benzodiazepines act through suppression. The combination does not create synergy for repair; one addresses symptoms while the other is explored for potential tissue-level support.\n\n## What the evidence actually shows\n\nNo human trials link VIP directly to benzodiazepine withdrawal (mechanistic tier). No rat studies address this combination (preclinical tier absent). General VIP research exists on autonomic and immune functions but does not extend to withdrawal models.\n\n## What scientists say\n\nVIP research focuses on vasodilation, gut motility, and immune modulation in other contexts. No published statements connect it specifically to benzo withdrawal repair pathways.\n\n## What people say on Reddit\n\nDiscussions on peptides for benzo withdrawal mention other compounds but contain no references to VIP (anecdotal tier, no relevant posts).\n\n## What people say on X\n\nNo posts discuss VIP in relation to benzodiazepine withdrawal (anecdotal tier, zero relevant results).\n\n## What we do not know\n\nDirect effects of VIP on GABA receptor recovery, autonomic symptoms in withdrawal, or long-term outcomes remain unknown. Human data is absent.\n\n## Safety and limits\n\nVIP has been studied in limited clinical settings for other conditions. No safety data exists for this use case. All claims here are graded by available evidence tiers with no human data supporting the specific application.","claims":[{"id":"c1","text":"Benzodiazepine withdrawal involves GABA receptor downregulation and autonomic shifts.","section":"What's breaking down if you have Benzodiazepine withdrawal","tier":"mechanistic","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Establishes baseline layers for the condition.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human trials or animal studies link VIP to benzodiazepine withdrawal.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights absence of direct evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Benzodiazepines provide GABAergic suppression without rebuilding neurochemistry.","section":"Why Benzodiazepines matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames suppression vs repair distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP is associated with autonomic and immune modulation in general studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s0"],"source_status":"sourced","why_material":"Provides basis for layer targeting discussion.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/7439634/","title":"Neural release of vasoactive intestinal peptide from the gut","quote":"The release of vasoactive intestinal peptide (VIP) from the canine gut and its possible neural origin were studied...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"medical","url":"https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+programs+and+practice+guidelines/substance+misuse+and+dependence/substance+withdrawal+management/benzodiazepine+withdrawal+management","title":"Benzodiazepine withdrawal management","quote":"Withdrawal is unlikely if the patient's use is intermittent only...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"other","url":"https://www.benzoinfo.com/bws/","title":"Benzodiazepine Withdrawal Syndrome (BWS)","quote":"People taking benzodiazepines regularly long term... may have symptoms of withdrawal...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":11009,"tokens_out":2336,"cost":0.01960125,"prev_hash":"genesis","hash":"620c395613764091d77e10555ee86fa13295362a2c708d5196ff3f71c06bdb9c"}],"provenance":[{"ts":"2026-06-29T22:36:58.639Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Benzo Withdrawal\nSlug: vip-benzo-withdrawal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Benzodiazepine withdrawal\",\"condition_key\":\"benzo-withdrawal\",\"primary_peptide\":\"vip\",\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[\"benzodiazepines\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Benzodiazepine withdrawal\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"benzodiazepines\",\"name\":\"Benzodiazepines\",\"section_title\":\"Why Benzodiazepines matters for you\",\"steps\":[\"**Drug:** Benzodiazepines\",\"**What it does:** GABAergic suppression; does not rebuild neurochemistry.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metaboli","response":"{\n  \"slug\": \"vip-benzo-withdrawal\",\n  \"title\": \"VIP for Benzodiazepine Withdrawal: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Benzodiazepine withdrawal\\n\\nBenzodiazepine withdrawal involves GABA receptor changes after prolonged use. The brain adapts to the drug's enhancement of GABA activity. When the drug is reduced or stopped, this adaptation can lead to rebound excitability.\\n\\nCommon layers include autonomic nervous system shifts (such as heart rate and blood pressure changes), possible immune signaling adjustments, and disrupted sleep or mood regulation. These elements can persist because repair pathways for receptor sensitivity and neural balance take time to restore.\\n\\nNo direct condition profile matched the slug, so layers are inferred from typical withdrawal descriptions: GABAergic suppression does not rebuild neurochemistry.\\n\\n## Why VIP might help you\\n\\n1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nVIP is studied in contexts of autonomic regulation and immune modulation. If autonomic instability contributes to symptoms during withdrawal, pathways involving VIP could relate to restoring balance rather than ongoing suppression.\\n\\n## Why Benzodiazepines matters for you\\n\\n**Drug:** Benzodiazepines\\n\\n**What it does:** GABAergic suppression; does not rebuild neurochemistry.\\n\\n**Therefore for you:** This drug suppresses a signal. It can reduce acute symptoms but trades off against repair by not addressing underlying receptor or autonomic changes. Long-term use may prolong the need for external support instead of natural restoration.\\n\\n## How these fit together\\n\\nSingle-compound focus — VIP targets the immune / autonomic layer. Benzodiazepines act through suppression. The combination does not create synergy","tokens_in":11009,"tokens_out":2336,"cost":0,"prev":"genesis","hash":"f2f914770483ec4527d83bcc5217d0319fc0356dea03010cec9019b23c38e794"},{"ts":"2026-07-17T02:43:21.555Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-benzo-withdrawal","response":"25 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f2f914770483ec4527d83bcc5217d0319fc0356dea03010cec9019b23c38e794","hash":"a372c9f8681782dfe72d0b8a1a2af8ef7760799b72939b52127d221b3e8def38"}],"energy":{"passes":2,"tokens_in":11009,"tokens_out":2336,"tokens_total":13345,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a372c9f8681782dfe72d0b8a1a2af8ef7760799b72939b52127d221b3e8def38"},"posted_at":"2026-06-29T21:33:48.199Z","created_at":"2026-06-29T21:33:48.199Z","updated_at":"2026-07-17T02:43:21.555Z","machine":{"shape":"article.machine/v1","slug":"vip-benzo-withdrawal","kind":"article","read":{"human":"https://miscsubjects.com/a/vip-benzo-withdrawal","json":"https://miscsubjects.com/api/articles/vip-benzo-withdrawal","bundle":"https://miscsubjects.com/api/articles/vip-benzo-withdrawal/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/vip-benzo-withdrawal/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=vip-benzo-withdrawal","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-benzo-withdrawal\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-benzo-withdrawal\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/vip-benzo-withdrawal/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"vip-benzo-withdrawal\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/vip-benzo-withdrawal | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/vip-benzo-withdrawal","json":"/api/articles/vip-benzo-withdrawal","markdown":"/api/articles/vip-benzo-withdrawal/bundle?format=markdown","skill":"/api/articles/vip-benzo-withdrawal/skill","topology":"/api/articles/vip-benzo-withdrawal/topology","versions":"/api/articles/vip-benzo-withdrawal/revisions","invocations":"/api/articles/vip-benzo-withdrawal/invocations"},"editorial_review":null,"editorial_audit":{"slug":"vip-benzo-withdrawal","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"c9ded8d299541d1f3cd25a2f44e598e02942053a3d730b9a17f3bae94e90635b","object":{"object_type":"article-object","identity":{"id":"article:vip-benzo-withdrawal","slug":"vip-benzo-withdrawal","title":"VIP for Benzodiazepine Withdrawal: Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/vip-benzo-withdrawal","role":"explain","audience":"human"},"skill":{"route":"/api/articles/vip-benzo-withdrawal/skill","role":"direct behavior","audience":"model","content":"---\nname: vip-benzo-withdrawal\ndescription: Apply the VIP for Benzodiazepine Withdrawal: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# VIP for Benzodiazepine Withdrawal: Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/vip-benzo-withdrawal). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/vip-benzo-withdrawal.\n- Read claims and relationships at /api/articles/vip-benzo-withdrawal/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Benzodiazepine withdrawal Benzodiazepine withdrawal involves GABA receptor changes after prolonged use. The brain adapts to the drug's enhancement of GABA activity. When the drug is reduced or stopped, this \n\n## Representations\n\n- Human: /a/vip-benzo-withdrawal\n- JSON: /api/articles/vip-benzo-withdrawal\n- Relationships: /api/articles/vip-benzo-withdrawal/topology\n- History: /api/articles/vip-benzo-withdrawal/revisions\n"},"json":{"route":"/api/articles/vip-benzo-withdrawal","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/vip-benzo-withdrawal/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","vip","benzo","withdrawal"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/vip-benzo-withdrawal/invocations?status=success","failure_events":"/api/articles/vip-benzo-withdrawal/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"vip-benzo-withdrawal","title":"VIP for Benzodiazepine Withdrawal: Evidence Review","body":"## What's breaking down if you have Benzodiazepine withdrawal\n\nBenzodiazepine withdrawal involves GABA receptor changes after prolonged use. The brain adapts to the drug's enhancement of GABA activity. When the drug is reduced or stopped, this adaptation can lead to rebound excitability.\n\nCommon layers include autonomic nervous system shifts (such as heart rate and blood pressure changes), possible immune signaling adjustments, and disrupted sleep or mood regulation. These elements can persist because repair pathways for receptor sensitivity and neural balance take time to restore.\n\nNo direct condition profile matched the slug, so layers are inferred from typical withdrawal descriptions: GABAergic suppression does not rebuild neurochemistry.\n\n## Why VIP might help you\n\n1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP is studied in contexts of autonomic regulation and immune modulation. If autonomic instability contributes to symptoms during withdrawal, pathways involving VIP could relate to restoring balance rather than ongoing suppression.\n\n## Why Benzodiazepines matters for you\n\n**Drug:** Benzodiazepines\n\n**What it does:** GABAergic suppression; does not rebuild neurochemistry.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce acute symptoms but trades off against repair by not addressing underlying receptor or autonomic changes. Long-term use may prolong the need for external support instead of natural restoration.\n\n## How these fit together\n\nSingle-compound focus — VIP targets the immune / autonomic layer. Benzodiazepines act through suppression. The combination does not create synergy for repair; one addresses symptoms while the other is explored for potential tissue-level support.\n\n## What the evidence actually shows\n\nNo human trials link VIP directly to benzodiazepine withdrawal (mechanistic tier). No rat studies address this combination (preclinical tier absent). General VIP research exists on autonomic and immune functions but does not extend to withdrawal models.\n\n## What scientists say\n\nVIP research focuses on vasodilation, gut motility, and immune modulation in other contexts. No published statements connect it specifically to benzo withdrawal repair pathways.\n\n## What people say on Reddit\n\nDiscussions on peptides for benzo withdrawal mention other compounds but contain no references to VIP (anecdotal tier, no relevant posts).\n\n## What people say on X\n\nNo posts discuss VIP in relation to benzodiazepine withdrawal (anecdotal tier, zero relevant results).\n\n## What we do not know\n\nDirect effects of VIP on GABA receptor recovery, autonomic symptoms in withdrawal, or long-term outcomes remain unknown. Human data is absent.\n\n## Safety and limits\n\nVIP has been studied in limited clinical settings for other conditions. No safety data exists for this use case. All claims here are graded by available evidence tiers with no human data supporting the specific application.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/vip-benzo-withdrawal/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Benzodiazepine withdrawal involves GABA receptor downregulation and autonomic shifts.","section":"What's breaking down if you have Benzodiazepine withdrawal","tier":"mechanistic","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Establishes baseline layers for the condition.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human trials or animal studies link VIP to benzodiazepine withdrawal.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights absence of direct evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Benzodiazepines provide GABAergic suppression without rebuilding neurochemistry.","section":"Why Benzodiazepines matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames suppression vs repair distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP is associated with autonomic and immune modulation in general studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s0"],"source_status":"sourced","why_material":"Provides basis for layer targeting discussion.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/7439634/","title":"Neural release of vasoactive intestinal peptide from the gut","quote":"The release of vasoactive intestinal peptide (VIP) from the canine gut and its possible neural origin were studied...","summary":"Early study on VIP release from gut with neural implications.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:36:44.808Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"8ef8841367ee6b107b87d9045d1eb756ddf7ff2cf20f6d2cca7be0d119e684a2"},{"id":"s2","type":"medical","url":"https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+programs+and+practice+guidelines/substance+misuse+and+dependence/substance+withdrawal+management/benzodiazepine+withdrawal+management","title":"Benzodiazepine withdrawal management","quote":"Withdrawal is unlikely if the patient's use is intermittent only...","summary":"Clinical guidance on benzo withdrawal symptoms and management.","claim_ids":["c1","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:36:44.808Z","link_status":"ok","quote_status":"unverified","prev":"8ef8841367ee6b107b87d9045d1eb756ddf7ff2cf20f6d2cca7be0d119e684a2","hash":"2df62194ee7d04175f224f6d4d94401b3c5c9b944c2f20105e9c9b8fbceda498"},{"id":"s3","type":"other","url":"https://www.benzoinfo.com/bws/","title":"Benzodiazepine Withdrawal Syndrome (BWS)","quote":"People taking benzodiazepines regularly long term... may have symptoms of withdrawal...","summary":"Overview of benzo withdrawal syndrome.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:36:44.808Z","link_status":"ok","quote_status":"unverified","prev":"2df62194ee7d04175f224f6d4d94401b3c5c9b944c2f20105e9c9b8fbceda498","hash":"4127573958086c85ca4a21dce5d4030131e910a0e7f8e1a6f37160a9e0a25da9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:36:58.639Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"VIP for Benzodiazepine Withdrawal: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Benzodiazepine withdrawal\n\nBenzodiazepine withdrawal involves GABA receptor changes after prolonged use. The brain adapts to the drug's enhancement of GABA activity. When the drug is reduced or stopped, this adaptation can lead to rebound excitability.\n\nCommon layers include autonomic nervous system shifts (such as heart rate and blood pressure changes), possible immune signaling adjustments, and disrupted sleep or mood regulation. These elements can persist because repair pathways for receptor sensitivity and neural balance take time to restore.\n\nNo direct condition profile matched the slug, so layers are inferred from typical withdrawal descriptions: GABAergic suppression does not rebuild neurochemistry.\n\n## Why VIP might help you\n\n1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP is studied in contexts of autonomic regulation and immune modulation. If autonomic instability contributes to symptoms during withdrawal, pathways involving VIP could relate to restoring balance rather than ongoing suppression.\n\n## Why Benzodiazepines matters for you\n\n**Drug:** Benzodiazepines\n\n**What it does:** GABAergic suppression; does not rebuild neurochemistry.\n\n**Therefore for you:** This drug suppresses a signal. It can reduce acute symptoms but trades off against repair by not addressing underlying receptor or autonomic changes. Long-term use may prolong the need for external support instead of natural restoration.\n\n## How these fit together\n\nSingle-compound focus — VIP targets the immune / autonomic layer. Benzodiazepines act through suppression. The combination does not create synergy for repair; one addresses symptoms while the other is explored for potential tissue-level support.\n\n## What the evidence actually shows\n\nNo human trials link VIP directly to benzodiazepine withdrawal (mechanistic tier). No rat studies address this combination (preclinical tier absent). General VIP research exists on autonomic and immune functions but does not extend to withdrawal models.\n\n## What scientists say\n\nVIP research focuses on vasodilation, gut motility, and immune modulation in other contexts. No published statements connect it specifically to benzo withdrawal repair pathways.\n\n## What people say on Reddit\n\nDiscussions on peptides for benzo withdrawal mention other compounds but contain no references to VIP (anecdotal tier, no relevant posts).\n\n## What people say on X\n\nNo posts discuss VIP in relation to benzodiazepine withdrawal (anecdotal tier, zero relevant results).\n\n## What we do not know\n\nDirect effects of VIP on GABA receptor recovery, autonomic symptoms in withdrawal, or long-term outcomes remain unknown. Human data is absent.\n\n## Safety and limits\n\nVIP has been studied in limited clinical settings for other conditions. No safety data exists for this use case. All claims here are graded by available evidence tiers with no human data supporting the specific application.","claims":[{"id":"c1","text":"Benzodiazepine withdrawal involves GABA receptor downregulation and autonomic shifts.","section":"What's breaking down if you have Benzodiazepine withdrawal","tier":"mechanistic","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Establishes baseline layers for the condition.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human trials or animal studies link VIP to benzodiazepine withdrawal.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Highlights absence of direct evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Benzodiazepines provide GABAergic suppression without rebuilding neurochemistry.","section":"Why Benzodiazepines matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames suppression vs repair distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"VIP is associated with autonomic and immune modulation in general studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s0"],"source_status":"sourced","why_material":"Provides basis for layer targeting discussion.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:36:46.988Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/7439634/","title":"Neural release of vasoactive intestinal peptide from the gut","quote":"The release of vasoactive intestinal peptide (VIP) from the canine gut and its possible neural origin were studied...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"medical","url":"https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+programs+and+practice+guidelines/substance+misuse+and+dependence/substance+withdrawal+management/benzodiazepine+withdrawal+management","title":"Benzodiazepine withdrawal management","quote":"Withdrawal is unlikely if the patient's use is intermittent only...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"other","url":"https://www.benzoinfo.com/bws/","title":"Benzodiazepine Withdrawal Syndrome (BWS)","quote":"People taking benzodiazepines regularly long term... may have symptoms of withdrawal...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":11009,"tokens_out":2336,"cost":0.01960125,"prev_hash":"genesis","hash":"620c395613764091d77e10555ee86fa13295362a2c708d5196ff3f71c06bdb9c"}],"provenance":[{"ts":"2026-06-29T22:36:58.639Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Benzo Withdrawal\nSlug: vip-benzo-withdrawal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Benzodiazepine withdrawal\",\"condition_key\":\"benzo-withdrawal\",\"primary_peptide\":\"vip\",\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[\"benzodiazepines\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Benzodiazepine withdrawal\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"benzodiazepines\",\"name\":\"Benzodiazepines\",\"section_title\":\"Why Benzodiazepines matters for you\",\"steps\":[\"**Drug:** Benzodiazepines\",\"**What it does:** GABAergic suppression; does not rebuild neurochemistry.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metaboli","response":"{\n  \"slug\": \"vip-benzo-withdrawal\",\n  \"title\": \"VIP for Benzodiazepine Withdrawal: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Benzodiazepine withdrawal\\n\\nBenzodiazepine withdrawal involves GABA receptor changes after prolonged use. The brain adapts to the drug's enhancement of GABA activity. When the drug is reduced or stopped, this adaptation can lead to rebound excitability.\\n\\nCommon layers include autonomic nervous system shifts (such as heart rate and blood pressure changes), possible immune signaling adjustments, and disrupted sleep or mood regulation. These elements can persist because repair pathways for receptor sensitivity and neural balance take time to restore.\\n\\nNo direct condition profile matched the slug, so layers are inferred from typical withdrawal descriptions: GABAergic suppression does not rebuild neurochemistry.\\n\\n## Why VIP might help you\\n\\n1. You are reading about **Benzodiazepine withdrawal** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nVIP is studied in contexts of autonomic regulation and immune modulation. If autonomic instability contributes to symptoms during withdrawal, pathways involving VIP could relate to restoring balance rather than ongoing suppression.\\n\\n## Why Benzodiazepines matters for you\\n\\n**Drug:** Benzodiazepines\\n\\n**What it does:** GABAergic suppression; does not rebuild neurochemistry.\\n\\n**Therefore for you:** This drug suppresses a signal. It can reduce acute symptoms but trades off against repair by not addressing underlying receptor or autonomic changes. Long-term use may prolong the need for external support instead of natural restoration.\\n\\n## How these fit together\\n\\nSingle-compound focus — VIP targets the immune / autonomic layer. Benzodiazepines act through suppression. The combination does not create synergy","tokens_in":11009,"tokens_out":2336,"cost":0,"prev":"genesis","hash":"f2f914770483ec4527d83bcc5217d0319fc0356dea03010cec9019b23c38e794"},{"ts":"2026-07-17T02:43:21.555Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-benzo-withdrawal","response":"25 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f2f914770483ec4527d83bcc5217d0319fc0356dea03010cec9019b23c38e794","hash":"a372c9f8681782dfe72d0b8a1a2af8ef7760799b72939b52127d221b3e8def38"}],"energy":{"passes":2,"tokens_in":11009,"tokens_out":2336,"tokens_total":13345,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a372c9f8681782dfe72d0b8a1a2af8ef7760799b72939b52127d221b3e8def38"},"posted_at":"2026-06-29T21:33:48.199Z","created_at":"2026-06-29T21:33:48.199Z","updated_at":"2026-07-17T02:43:21.555Z","machine":{"shape":"article.machine/v1","slug":"vip-benzo-withdrawal","kind":"article","read":{"human":"https://miscsubjects.com/a/vip-benzo-withdrawal","json":"https://miscsubjects.com/api/articles/vip-benzo-withdrawal","bundle":"https://miscsubjects.com/api/articles/vip-benzo-withdrawal/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/vip-benzo-withdrawal/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=vip-benzo-withdrawal","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-benzo-withdrawal\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-benzo-withdrawal\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/vip-benzo-withdrawal/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"vip-benzo-withdrawal\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/vip-benzo-withdrawal | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/vip-benzo-withdrawal","json":"/api/articles/vip-benzo-withdrawal","markdown":"/api/articles/vip-benzo-withdrawal/bundle?format=markdown","skill":"/api/articles/vip-benzo-withdrawal/skill","topology":"/api/articles/vip-benzo-withdrawal/topology","versions":"/api/articles/vip-benzo-withdrawal/revisions","invocations":"/api/articles/vip-benzo-withdrawal/invocations"},"editorial_review":null,"editorial_audit":{"slug":"vip-benzo-withdrawal","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"c9ded8d299541d1f3cd25a2f44e598e02942053a3d730b9a17f3bae94e90635b"}}}